{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:03:44Z","timestamp":1792047824192,"version":"4.4.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T00:00:00Z","timestamp":1592438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T00:00:00Z","timestamp":1592438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81630029"],"award-info":[{"award-number":["81630029"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81871005"],"award-info":[{"award-number":["81871005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Key R&D Program of China","award":["2016YFC13060000"],"award-info":[{"award-number":["2016YFC13060000"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In Alzheimer\u2019s Disease (AD), about one-third of the risk genes identified by GWAS encode proteins that function predominantly in the endocytic pathways. Among them, the Ras and Rab Interactor 3(RIN3) is a guanine nucleotide exchange factor (GEF) for the Rab5 small GTPase family and has been implicated to be a risk factor for both late onset AD (LOAD) and sporadic early onset AD (sEOAD). However, how RIN3 is linked to AD pathogenesis is currently undefined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Quantitative PCR and immunoblotting were used to measure the RIN3 expression level in mouse brain tissues and cultured basal forebrain cholinergic neuron (BFCNs). Immunostaining was used to define subcellular localization of RIN3 and to visualize endosomal changes in cultured primary BFCNs and PC12 cells. Recombinant flag-tagged RIN3 protein was purified from HEK293T cells and was used to define RIN3-interactomes by mass spectrometry. RIN3-interacting partners were validated by co-immunoprecipitation, immunofluorescence and yeast two hybrid assays. Live imaging of primary neurons was used to examine axonal transport of amyloid precursor protein (APP) and \u03b2-secretase 1 (BACE1). Immunoblotting was used to detect protein expression, processing of APP and phosphorylated forms of Tau.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We have shown that RIN3 mRNA level was significantly increased in the hippocampus and cortex of APP\/PS1 mouse brain. Basal forebrain cholinergic neurons (BFCNs) cultured from E18 APP\/PS1 mouse embryos also showed increased RIN3 expression accompanied by early endosome enlargement. In addition, via its proline rich domain, RIN3 recruited BIN1(bridging integrator 1) and CD2AP (CD2 associated protein), two other AD risk factors, to early endosomes. Interestingly, overexpression of RIN3 or CD2AP promoted APP cleavage to increase its carboxyl terminal fragments (CTFs) in PC12 cells. Upregulation of RIN3 or the neuronal isoform of BIN1 increased phosphorylated Tau level. Therefore, upregulation of RIN3 expression promoted accumulation of APP CTFs and increased phosphorylated Tau. These effects by RIN3 was rescued by the expression of a dominant negative Rab5 (Rab5\n                      <jats:sup>S34N<\/jats:sup>\n                      ) construct. Our study has thus pointed to that RIN3 acts through Rab5 to impact endosomal trafficking and signaling.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>RIN3 is significantly upregulated and correlated with endosomal dysfunction in APP\/PS1 mouse. Through interacting with BIN1 and CD2AP, increased RIN3 expression alters axonal trafficking and procession of APP. Together with our previous studies, our current work has thus provided important insights into the role of RIN3 in regulating endosomal signaling and trafficking.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40035-020-00206-1","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T04:02:47Z","timestamp":1592452967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Upregulation of RIN3 induces endosomal dysfunction in Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"9","author":[{"given":"Ruinan","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbo","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzhen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savannah","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanlin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kijung","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Rissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3660-088X","authenticated-orcid":false,"given":"Chengbiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,18]]},"reference":[{"key":"206_CR1","doi-asserted-by":"crossref","unstructured":"Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Mol Med. 2016;8(6):595\u2013608.","DOI":"10.15252\/emmm.201606210"},{"key":"206_CR2","doi-asserted-by":"crossref","unstructured":"Karch C M, Cruchaga C, Goate A M. Alzheimer\u2019s disease genetics: from the bench to the clinic[J]. Neuron. 2014;83(1):11\u201326.","DOI":"10.1016\/j.neuron.2014.05.041"},{"key":"206_CR3","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez DB, Soldevilla MAG, Santiago AP, et al. Enfermedad de alzheimer[J]. Medicine-Programa de Formaci\u00f3n M\u00e9dica Continuada Acreditado. 2019;12(74):4338\u201346.","DOI":"10.1016\/j.med.2019.03.012"},{"key":"206_CR4","doi-asserted-by":"crossref","unstructured":"Karch C M, Goate A M. Alzheimer\u2019s disease risk genes and mechanisms of disease pathogenesis[J]. Biol Psychiatry. 2015;77(1):43\u201351.","DOI":"10.1016\/j.biopsych.2014.05.006"},{"key":"206_CR5","doi-asserted-by":"crossref","unstructured":"Doody RS, Aisen PS, Iwatsubo T. Semagacestat for treatment of Alzheimer's disease. N Engl J Med. 2013;369(17):1661.","DOI":"10.1056\/NEJMc1310845"},{"key":"206_CR6","doi-asserted-by":"crossref","unstructured":"Doody RS, Raman R, Farlow M, Iwatsubo T, Vellas B, Joffe S, et al. A phase 3 trial of Semagacestat for treatment of Alzheimer's disease. N Engl J Med. 2013;369(4):341\u201350.","DOI":"10.1056\/NEJMoa1210951"},{"key":"206_CR7","doi-asserted-by":"crossref","unstructured":"Gauthier S, Feldman HH, Schneider LS, Wilcock GK, Frisoni GB, Hardlund JH, et al. Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial. Lancet. 2016;388(10062):2873\u201384.","DOI":"10.1016\/S0140-6736(16)31275-2"},{"key":"206_CR8","doi-asserted-by":"crossref","unstructured":"Mahley RW, Weisgraber KH, Huang Y. Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS. J Lipid Res. 2009;50 Suppl:S183\u20138.","DOI":"10.1194\/jlr.R800069-JLR200"},{"key":"206_CR9","doi-asserted-by":"crossref","unstructured":"Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S, et al. Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry. 2006;63(2):168\u201374.","DOI":"10.1001\/archpsyc.63.2.168"},{"key":"206_CR10","doi-asserted-by":"crossref","unstructured":"Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet. 2009;41:1088\u201393.","DOI":"10.1038\/ng.440"},{"issue":"11","key":"206_CR11","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/mp.2013.1","volume":"18","author":"J Chapuis","year":"2013","unstructured":"Chapuis J, Hansmannel F, Gistelinck M, Mounier A, Van Cauwenberghe C, Kolen KV, et al. Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry. 2013;18(11):1225\u201334.","journal-title":"Mol Psychiatry"},{"key":"206_CR12","doi-asserted-by":"crossref","unstructured":"Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA. 2010;303(18):1832\u201340.","DOI":"10.1001\/jama.2010.574"},{"key":"206_CR13","doi-asserted-by":"crossref","unstructured":"Sherva R, Baldwin CT, Inzelberg R, Vardarajan B, Cupples LA, Lunetta K, et al. Identification of novel candidate genes for Alzheimer's disease by autozygosity mapping using genome wide SNP data. J Alzheimers Dis. 2011;23(2):349\u201359.","DOI":"10.3233\/JAD-2010-100714"},{"key":"206_CR14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0002-9440(10)64538-5","volume":"157","author":"AM Cataldo","year":"2000","unstructured":"Cataldo AM, Peterhoff CM, Troncoso JC, Gomez-Isla T, Hyman BT, Nixon RA. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am J Pathol. 2000;157:277\u201386.","journal-title":"Am J Pathol"},{"key":"206_CR15","doi-asserted-by":"crossref","unstructured":"Ginsberg SD, Mufson EJ, Alldred MJ, Counts SE, Wuu J, Nixon RA, et al. Upregulation of select rab GTPases in cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease. J Chem Neuroanat. 2011;42(2):102\u201310.","DOI":"10.1016\/j.jchemneu.2011.05.012"},{"key":"206_CR16","doi-asserted-by":"crossref","unstructured":"Ginsberg SD, Mufson EJ, Counts SE, Wuu J, Alldred MJ, Nixon RA, et al. Regional selectivity of rab5 and rab7 protein upregulation in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis. 2010;22(2):631\u20139.","DOI":"10.3233\/JAD-2010-101080"},{"key":"206_CR17","doi-asserted-by":"crossref","unstructured":"Nixon RA. Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseases[J]. Neurobiol Aging. 2005;26(3):373\u201382.","DOI":"10.1016\/j.neurobiolaging.2004.09.018"},{"key":"206_CR18","doi-asserted-by":"crossref","unstructured":"Cataldo AM, Petanceska S, Terio NB, Peterhoff CM, Durham R, Mercken M, et al. A\u03b2 localization in abnormal endosomes: association with earliest A\u03b2 elevations in AD and Down syndrome. Neurobiol Aging. 2004;25(10):1263\u201372.","DOI":"10.1016\/j.neurobiolaging.2004.02.027"},{"key":"206_CR19","doi-asserted-by":"crossref","unstructured":"Kinoshita A. Demonstration by FRET of BACE interaction with the amyloid precursor protein at the cell surface and in early endosomes. J Cell Sci. 2003;116(Pt 16):3339\u201346.","DOI":"10.1242\/jcs.00643"},{"key":"206_CR20","doi-asserted-by":"crossref","unstructured":"Thinakaran G, Koo EH. Amyloid precursor protein trafficking, processing, and function[J]. J Biol Chem. 2008;283(44):29615\u20139.","DOI":"10.1074\/jbc.R800019200"},{"issue":"5","key":"206_CR21","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1172\/JCI82409","volume":"126","author":"W Xu","year":"2016","unstructured":"Xu W, Weissmiller AM, White JA 2nd, Fang F, Wang X, Wu Y, et al. Amyloid precursor protein-mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration. J Clin Invest. 2016;126(5):1815\u201333.","journal-title":"J Clin Invest"},{"issue":"2","key":"206_CR22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41431-018-0273-5","volume":"27","author":"N Tesi","year":"2019","unstructured":"Tesi N, van der Lee SJ, Hulsman M, Jansen IE, Stringa N, van Schoor N, et al. Centenarian controls increase variant effect sizes by an average twofold in an extreme case\u2013extreme control analysis of Alzheimer\u2019s disease. Eur J Hum Genet. 2019;27(2):244\u201353.","journal-title":"Eur J Hum Genet"},{"issue":"9","key":"206_CR23","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/jamaneurol.2017.1518","volume":"74","author":"BW Kunkle","year":"2017","unstructured":"Kunkle BW, Vardarajan BN, Naj AC, Whitehead PL, Rolati S, Slifer S, et al. Early-onset Alzheimer disease and candidate risk genes involved in Endolysosomal transport. JAMA Neurol. 2017;74(9):1113\u201322.","journal-title":"JAMA Neurol"},{"key":"206_CR24","doi-asserted-by":"crossref","unstructured":"Boden KA, Barber IS, Clement N, Patel T, Guetta-Baranes T, Brookes KJ, et al. Methylation Profiling RIN3 and MEF2C Identifies Epigenetic Marks Associated with Sporadic Early Onset Alzheimer's Disease. J Alzheimers Dis Rep. 2017;1(1):97\u2013108.","DOI":"10.3233\/ADR-170015"},{"key":"206_CR25","doi-asserted-by":"publisher","unstructured":"Pathak GAS, Talisa K, Sun J, Zhou Z, Daniel AA, Johnson L, O\u2019Bryant S, Phillips NR, Barber RC. Genome-Wide Methylation of Mild Cognitive Impairment in Mexican Americans Highlights Genes Involved in Synaptic Transport, Alzheimer\u2019s Disease-Precursor Phenotypes, and Metabolic Morbidities. J Alzheimer's Dis. 2019. Pre-press. https:\/\/doi.org\/10.3233\/JAD-190634.","DOI":"10.3233\/JAD-190634"},{"key":"206_CR26","doi-asserted-by":"crossref","unstructured":"Kajiho H. RIN3: a novel Rab5 GEF interacting with amphiphysin II involved in the early endocytic pathway. J Cell Sci. 2003;116:4159\u201368.","DOI":"10.1242\/jcs.00718"},{"key":"206_CR27","doi-asserted-by":"crossref","unstructured":"Kajiho H, Sakurai K, Minoda T, Yoshikawa M, Nakagawa S, Fukushima S, et al. Characterization of RIN3 as a guanine nucleotide exchange factor for the Rab5 subfamily GTPase Rab31. Biol Chem. 2011;286(27):24364\u201373.","DOI":"10.1074\/jbc.M110.172445"},{"key":"206_CR28","doi-asserted-by":"crossref","unstructured":"Grbovic OM, Mathews PM, Jiang Y, Schmidt SD, Dinakar R, Summers-Terio NB, et al. Rab5-stimulated up-regulation of the endocytic pathway increases intracellular \u03b2-cleaved amyloid precursor protein carboxyl-terminal fragment levels and A\u03b2 production. J Biol Chem. 2003;278(33):31261\u20138.","DOI":"10.1074\/jbc.M304122200"},{"key":"206_CR29","doi-asserted-by":"crossref","unstructured":"Bucci C, Parton R G, Mather I H, et al. The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway[J]. Cell. 1992;70(5):715\u201328.","DOI":"10.1016\/0092-8674(92)90306-W"},{"key":"206_CR30","doi-asserted-by":"crossref","unstructured":"Gorvel JP, Chavrier P, Zerial M, Gruenberg J. rab5 controls early endosome fusion in vitro. Cell. 1991;64(5):915\u20132.","DOI":"10.1016\/0092-8674(91)90316-Q"},{"key":"206_CR31","doi-asserted-by":"crossref","unstructured":"Schnitzler AC, Lopez-Coviella I, Blusztajn JK. Purification and culture of nerve growth factor receptor (p75)-expressing basal forebrain cholinergic neurons. Nat Protoc. 2008;3(1):34\u201340.","DOI":"10.1038\/nprot.2007.477"},{"issue":"14","key":"206_CR32","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1523\/JNEUROSCI.1686-17.2018","volume":"38","author":"K Sung","year":"2018","unstructured":"Sung K, Ferrari LF, Yang W, Chung C, Zhao X, Gu Y, et al. Swedish nerve growth factor mutation (NGF(R100W)) defines a role for TrkA and p75(NTR) in nociception. J Neurosci. 2018;38(14):3394\u2013413.","journal-title":"J Neurosci"},{"key":"206_CR33","doi-asserted-by":"crossref","unstructured":"Br\u00fcckner A, Polge C, Lentze N, et al. Yeast two-hybrid, a powerful tool for systems biology[J]. Int J Mol Sci. 2009;10(6):2763\u201388.","DOI":"10.3390\/ijms10062763"},{"issue":"1","key":"206_CR34","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1038\/s41598-017-04232-4","volume":"7","author":"F Fang","year":"2017","unstructured":"Fang F, Yang W, Florio JB, Rockenstein E, Spencer B, Orain XM, et al. Synuclein impairs trafficking and signaling of BDNF in a mouse model of Parkinson's disease. Sci Rep. 2017;7(1):3868.","journal-title":"Sci Rep"},{"issue":"3","key":"206_CR35","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.nbd.2006.08.017","volume":"24","author":"M Garcia-Alloza","year":"2006","unstructured":"Garcia-Alloza M, Robbins EM, Zhang-Nunes SX, Purcell SM, Betensky RA, Raju S, et al. Characterization of amyloid deposition in the APPswe\/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis. 2006;24(3):516\u201324.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"206_CR36","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/hmg\/ddh019","volume":"13","author":"JL Jankowsky","year":"2004","unstructured":"Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, et al. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet. 2004;13(2):159\u201370.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"206_CR37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neulet.2005.08.028","volume":"390","author":"R Lalonde","year":"2005","unstructured":"Lalonde R, Kim HD, Maxwell JA, Fukuchi K. Exploratory activity and spatial learning in 12-month-old APP(695)SWE\/co+PS1\/DeltaE9 mice with amyloid plaques. Neurosci Lett. 2005;390(2):87\u201392.","journal-title":"Neurosci Lett"},{"key":"206_CR38","volume":"3","author":"H Wu","year":"2014","unstructured":"Wu H, Williams J, Nathans J. Complete morphologies of basal forebrain cholinergic neurons in the mouse. Elife. 2014;3:e02444.","journal-title":"Elife."},{"key":"206_CR39","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fnins.2019.00446","volume":"13","author":"XQ Chen","year":"2019","unstructured":"Chen XQ, Mobley WC. Exploring the pathogenesis of Alzheimer disease in basal forebrain cholinergic neurons: converging insights from alternative hypotheses. Front Neurosci. 2019;13:446.","journal-title":"Front Neurosci"},{"key":"206_CR40","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fnins.2019.00129","volume":"13","author":"M Fahnestock","year":"2019","unstructured":"Fahnestock M, Shekari A. ProNGF and Neurodegeneration in Alzheimer's Disease. Front Neurosci. 2019;13:129.","journal-title":"Front Neurosci"},{"issue":"4","key":"206_CR41","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.neurobiolaging.2012.10.018","volume":"34","author":"M Grothe","year":"2013","unstructured":"Grothe M, Heinsen H, Teipel S. Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer's disease. Neurobiol Aging. 2013;34(4):1210\u201320.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"206_CR42","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00702-003-0091-x","volume":"111","author":"A Salehi","year":"2004","unstructured":"Salehi A, Delcroix JD, Swaab DF. Alzheimer's disease and NGF signaling. J Neural Transm (Vienna). 2004;111(3):323\u201345.","journal-title":"J Neural Transm (Vienna)"},{"issue":"2","key":"206_CR43","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.bbr.2010.11.058","volume":"221","author":"R Schliebs","year":"2011","unstructured":"Schliebs R, Arendt T. The cholinergic system in aging and neuronal degeneration. Behav Brain Res. 2011;221(2):555\u201363.","journal-title":"Behav Brain Res"},{"issue":"1","key":"206_CR44","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1038\/s41598-019-41654-8","volume":"9","author":"Y Xie","year":"2019","unstructured":"Xie Y, Meeker RB, Massa SM, Longo FM. Modulation of the p75 neurotrophin receptor suppresses age-related basal forebrain cholinergic neuron degeneration. Sci Rep. 2019;9(1):5273.","journal-title":"Sci Rep"},{"issue":"15","key":"206_CR45","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1523\/JNEUROSCI.2423-15.2016","volume":"36","author":"BJ Harrison","year":"2016","unstructured":"Harrison BJ, Venkat G, Lamb JL, Hutson TH, Drury C, Rau KK, et al. The adaptor protein CD2AP is a coordinator of Neurotrophin signaling-mediated axon arbor plasticity. J Neurosci. 2016;36(15):4259.","journal-title":"J Neurosci"},{"issue":"Pt 23","key":"206_CR46","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1242\/jcs.113688","volume":"125","author":"K Balaji","year":"2012","unstructured":"Balaji K, Mooser C, Janson CM, Bliss JM, Hojjat H, Colicelli J. RIN1 orchestrates the activation of RAB5 GTPases and ABL tyrosine kinases to determine the fate of EGFR. J Cell Sci. 2012;125(Pt 23):5887\u201396.","journal-title":"J Cell Sci"},{"key":"206_CR47","doi-asserted-by":"crossref","unstructured":"Rouka E, Simister PC, Janning M, Kumbrink J, Konstantinou T, Muniz JRC, et al. Differential recognition preferences of the three Src homology 3 (SH3) domains from the adaptor CD2-associated protein (CD2AP) and direct association with Ras and Rab Interactor 3 (RIN3). J Biol Chem. 2015;290(42):25275\u201392.","DOI":"10.1074\/jbc.M115.637207"},{"key":"206_CR48","doi-asserted-by":"crossref","unstructured":"Almeida CG, Mirfakhar FS, Perdig\u00e3o C, et al. Impact of late-onset Alzheimer\u2019s genetic risk factors on beta-amyloid endocytic production[J]. Cell Mol Life Sci. 2018;75(14):2577\u201389.","DOI":"10.1007\/s00018-018-2825-9"},{"key":"206_CR49","doi-asserted-by":"crossref","unstructured":"Karch CM, Jeng AT, Nowotny P, Cady J, Cruchaga C, Goate AM. Expression of Novel Alzheimer's Disease Risk Genes in Control and Alzheimer's Disease Brains. PLoS One (IF: 2.776). 2012;7(11):e50976.","DOI":"10.1371\/journal.pone.0050976"},{"key":"206_CR50","doi-asserted-by":"crossref","unstructured":"Holler CJ, Davis PR, Beckett TL, Platt TL, Webb RL, Head E, et al. Bridging integrator 1 (BIN1) protein expression increases in the alzheimer's disease brain and correlates with neurofibrillary tangle pathology. J Alzheimers Dis. 2014;42(4):1221\u20137.","DOI":"10.3233\/JAD-132450"},{"key":"206_CR51","doi-asserted-by":"crossref","unstructured":"Andrew RJ, De Rossi P, Nguyen P, Kowalski HR, Recupero AJ, Guerbette T, et al. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor BIN1 does not affect amyloid pathology in an AD mouse model. J Biol Chem. 2019;294(12):4477\u201387.","DOI":"10.1074\/jbc.RA118.006379"},{"key":"206_CR52","doi-asserted-by":"crossref","unstructured":"Ubelmann F, Burrinha T, Salavessa L, Gomes R, Ferreira C, Moreno N, et al. Bin1 and CD2AP polarise the endocytic generation of beta-amyloid. EMBO Rep. 2017;18(1):102\u201322.","DOI":"10.15252\/embr.201642738"},{"key":"206_CR53","doi-asserted-by":"crossref","unstructured":"Kwart D, Gregg A, Scheckel C, Murphy E, Paquet D, Duffield M, et al. A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared Endosomal abnormalities mediated by APP beta-CTFs, Not Abeta. Neuron. 2019;104(2):256\u2013270.e5.","DOI":"10.1016\/j.neuron.2019.07.010"},{"key":"206_CR54","doi-asserted-by":"crossref","unstructured":"Juul Rasmussen I, Tybj\u00e6rg-Hansen A, Rasmussen KL, Nordestgaard BG, Frikke-Schmidt R. Blood\u2013brain barrier transcytosis genes, risk of dementia and stroke: a prospective cohort study of 74,754 individuals. Eur J Epidemiol. 2019;34(6):579\u201390.","DOI":"10.1007\/s10654-019-00498-2"},{"key":"206_CR55","doi-asserted-by":"crossref","unstructured":"Bogdanovi\u0107 O, Lister R. DNA methylation and the preservation of cell identity[J]. Curr Opin Genet Dev. 2017;46:9\u201314.","DOI":"10.1016\/j.gde.2017.06.007"},{"key":"206_CR56","doi-asserted-by":"crossref","unstructured":"Blanchard V, Moussaoui S, Czech C, Touchet N, Bonici B, Planche M, et al. Time sequence of maturation of dystrophic neurites associated with A\u03b2 deposits in APP\/PS1 transgenic mice. Exp Neurol. 2003;184(1):247\u201363.","DOI":"10.1016\/S0014-4886(03)00252-8"},{"key":"206_CR57","doi-asserted-by":"crossref","unstructured":"Toh WH, Gleeson PA. Dysregulation of intracellular trafficking and endosomal sorting in Alzheimer's disease: controversies and unanswered questions. Biochem J. 2016;473(14):1977\u201393.","DOI":"10.1042\/BCJ20160147"},{"key":"206_CR58","doi-asserted-by":"crossref","unstructured":"Spencer B, Desplats P A, Overk C R, et al. Reducing endogenous \u03b1-synuclein mitigates the degeneration of selective neuronal populations in an Alzheimer's disease transgenic mouse model[J]. J Neurosci. 2016;36(30):7971\u201384.","DOI":"10.1523\/JNEUROSCI.0775-16.2016"},{"key":"206_CR59","doi-asserted-by":"crossref","unstructured":"Koo EH, Squazzo SL. Evidence that production and release of amyloid ??-protein involves the endocytic pathway. J Biol Chem. 1994.","DOI":"10.1016\/S0021-9258(17)32449-3"},{"issue":"27","key":"206_CR60","doi-asserted-by":"crossref","first-page":"7141","DOI":"10.1523\/JNEUROSCI.4599-06.2007","volume":"27","author":"D Laifenfeld","year":"2007","unstructured":"Laifenfeld D, Patzek LJ, McPhie DL, Chen Y, Levites Y, Cataldo AM, et al. Rab5 mediates an amyloid precursor protein signaling pathway that leads to apoptosis. J Neurosci. 2007;27(27):7141\u201353.","journal-title":"J Neurosci"},{"issue":"46","key":"206_CR61","doi-asserted-by":"crossref","first-page":"16243","DOI":"10.1523\/JNEUROSCI.2775-12.2012","volume":"32","author":"I Lauritzen","year":"2012","unstructured":"Lauritzen I, Pardossi-Piquard R, Bauer C, Brigham E, Abraham JD, Ranaldi S, et al. The beta-secretase-derived C-terminal fragment of betaAPP, C99, but not Abeta, is a key contributor to early intraneuronal lesions in triple-transgenic mouse hippocampus. J Neurosci. 2012;32(46):16243\u201355a.","journal-title":"J Neurosci"},{"issue":"2","key":"206_CR62","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00401-016-1577-6","volume":"132","author":"I Lauritzen","year":"2016","unstructured":"Lauritzen I, Pardossi-Piquard R, Bourgeois A, Pagnotta S, Biferi MG, Barkats M, et al. Intraneuronal aggregation of the beta-CTF fragment of APP (C99) induces Abeta-independent lysosomal-autophagic pathology. Acta Neuropathol. 2016;132(2):257\u201376.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"206_CR63","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/bpa.12687","volume":"29","author":"P De Rossi","year":"2019","unstructured":"De Rossi P, Andrew RJ, Musial TF, Buggia-Prevot V, Xu G, Ponnusamy M, et al. Aberrant accrual of BIN1 near Alzheimer's disease amyloid deposits in transgenic models. Brain Pathol. 2019;29(4):485\u2013501.","journal-title":"Brain Pathol"},{"key":"206_CR64","doi-asserted-by":"crossref","unstructured":"De Rossi P, Buggia-Pr\u00e9vot V, Clayton BLL, Vasquez JB, Van Sanford C, Andrew RJ, et al. Predominant expression of Alzheimer's disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts. Mol Neurodegener. 2016;11(1):59.","DOI":"10.1186\/s13024-016-0124-1"},{"key":"206_CR65","doi-asserted-by":"crossref","unstructured":"Liao F, Jiang H, Srivatsan S, Xiao Q, Lefton KB, Yamada K, et al. Effects of CD2-associated protein deficiency on amyloid-\u03b2 in neuroblastoma cells and in an APP transgenic mouse model. Mol Neurodegener. 2015;10:12.","DOI":"10.1186\/s13024-015-0006-y"},{"issue":"19","key":"206_CR66","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1111\/febs.14185","volume":"284","author":"I Malki","year":"2017","unstructured":"Malki I, Cantrelle FX, Sottejeau Y, Lippens G, Lambert JC, Landrieu I. Regulation of the interaction between the neuronal BIN1 isoform 1 and tau proteins - role of the SH3 domain. FEBS J. 2017;284(19):3218\u201329.","journal-title":"FEBS J"},{"key":"206_CR67","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40478-015-0237-8","volume":"3","author":"Y Sottejeau","year":"2015","unstructured":"Sottejeau Y, Bretteville A, Cantrelle FX, Malmanche N, Demiaute F, Mendes T, et al. Tau phosphorylation regulates the interaction between BIN1's SH3 domain and Tau's proline-rich domain. Acta Neuropathol Commun. 2015;3:58.","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"206_CR68","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.celrep.2016.09.063","volume":"17","author":"S Calafate","year":"2016","unstructured":"Calafate S, Flavin W, Verstreken P, Moechars D. Loss of Bin1 promotes the propagation of tau pathology. Cell Rep. 2016;17(4):931\u201340.","journal-title":"Cell Rep"},{"issue":"1","key":"206_CR69","doi-asserted-by":"crossref","first-page":"9477","DOI":"10.1038\/s41598-019-45676-0","volume":"9","author":"A Crotti","year":"2019","unstructured":"Crotti A, Sait HR, McAvoy KM, Estrada K, Ergun A, Szak S, et al. BIN1 favors the spreading of tau via extracellular vesicles. Sci Rep. 2019;9(1):9477.","journal-title":"Sci Rep"},{"issue":"10","key":"206_CR70","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1016\/j.celrep.2020.02.026","volume":"30","author":"P De Rossi","year":"2020","unstructured":"De Rossi P, Nomura T, Andrew RJ, Masse NY, Sampathkumar V, Musial TF, et al. Neuronal BIN1 regulates presynaptic neurotransmitter release and memory consolidation. Cell Rep. 2020;30(10):3520\u201335 e7.","journal-title":"Cell Rep"},{"issue":"2","key":"206_CR71","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"DV Hansen","year":"2018","unstructured":"Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer\u2019s disease. J Cell Biol. 2018;217(2):459.","journal-title":"J Cell Biol"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-020-00206-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-020-00206-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-020-00206-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T01:19:48Z","timestamp":1667006388000},"score":1,"resource":{"primary":{"URL":"https:\/\/translationalneurodegeneration.biomedcentral.com\/articles\/10.1186\/s40035-020-00206-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,18]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["206"],"URL":"https:\/\/doi.org\/10.1186\/s40035-020-00206-1","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,18]]},"assertion":[{"value":"18 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}